193 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
NVO Novo Nordisk A/S $47.64 $114.84B N/A
Article Searches
Novo Nordisk & 4 Other Pharma Stocks in Focus on World Diabetes Day http://www.zacks.com/stock/news/282791/novo-nordisk-4-other-pharma-stocks-in-focus-on-world-diabetes-day?cid=CS-ZC-FT-282791 Nov 14, 2017 - Despite pricing pressure & competition, the diabetes market remains lucrative given the prevalence of the disease and demand for better treatments. Novo Nordisk (NVO) is a key player in this market.
Novo Nordisk A/S Slogs Through the Year https://www.fool.com/investing/2017/11/07/novo-nordisk-as-slogs-through-the-year.aspx?source=iedfolrf0000001 Nov 07, 2017 - It was another lackluster quarter from the diabetes specialist.
Foreign Stock Roundup: Alibaba, Sinopec, BP, Novo Nordisk Beat on Earnings http://www.zacks.com/stock/news/281824/foreign-stock-roundup-alibaba-sinopec-bp-novo-nordisk-beat-on-earnings?cid=CS-ZC-FT-281824 Nov 06, 2017 - Earnings results largely guided stocks across Europe and China over last week.
The 3 Best Diabetes Stocks to Buy in 2018 https://www.fool.com/investing/2017/10/30/the-3-best-diabetes-stocks-to-buy-in-2018.aspx?source=iedfolrf0000001 Oct 30, 2017 - Not all diabetes stocks are created equally.
Novo Nordisk (NVO) Presents At 22nd HR Shared Services 7 Outsourcing Summit - Slideshow https://seekingalpha.com/article/4114760-novo-nordisk-nvo-presents-22nd-hr-shared-services-7-outsourcing-summit-slideshow?source=feed_sector_healthcare Oct 19, 2017 - The following slide deck was published by Novo Nordisk A/S in conjunction with this event.
Why MannKind Corporation Popped Today https://www.fool.com/investing/2017/10/02/why-mannkind-corporation-popped-today.aspx?source=iedfolrf0000001 Oct 02, 2017 - Traders cheer after management provided investors with a series of positive updates.
Here's Why Novo Nordisk A/S Gained 12% in August https://www.fool.com/investing/2017/09/06/heres-why-novo-nordisk-as-gained-12-in-august.aspx?source=iedfolrf0000001 Sep 06, 2017 - Last summer, the diabetes-focused pharmaceutical issued distressing guidance due to pricing pressure worries, but the forecast troubles failed to arrive.
3 High-Yield Pharmaceutical Stocks https://www.fool.com/investing/2017/08/22/3-high-yield-pharmaceutical-stocks.aspx?source=iedfolrf0000001 Aug 22, 2017 - Pfizer, GlaxoSmithKline, and Novo Nordisk all offer up temptingly high yields. Here's why they're worth putting on your radar.
Novo Nordisk A/S Continues Its Comeback https://www.fool.com/investing/2017/08/14/novo-nordisk-as-continues-its-comeback.aspx?source=iedfolrf0000001 Aug 14, 2017 - A solid-enough second quarter from the diabetes specialist boosts investors' confidence in a turnaround.
Novo Nordisk's (NVO) CEO Lars Fruergaard Jorgensen on Q2 2017 Results - Earnings Call Transcript https://seekingalpha.com/article/4097095-novo-nordisks-nvo-ceo-lars-fruergaard-jorgensen-q2-2017-results-earnings-call-transcript?source=feed_all_articles Aug 09, 2017 - Novo Nordisk A/S (NYSE:NVO) Q2 2017 Earnings Conference Call August 9, 2017 7:00 AM ET Executives Lars Fruergaard Jorgensen – President and Chief Executive Officer Mads Krogsgaard Thomsen – Executive

Pages: 1...11121314151617181920

<<<Page 16>